GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 48 filers reported holding GALERA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $64,898 | -94.5% | 370,643 | -1.1% | 0.00% | – |
Q2 2023 | $1,169,341 | +43.0% | 374,789 | +17.3% | 0.00% | – |
Q1 2023 | $817,971 | +84.6% | 319,520 | +7.5% | 0.00% | – |
Q4 2022 | $443,010 | -18.4% | 297,323 | -4.8% | 0.00% | – |
Q3 2022 | $543,000 | +32.4% | 312,230 | -0.8% | 0.00% | – |
Q2 2022 | $410,000 | -46.4% | 314,659 | -2.1% | 0.00% | – |
Q1 2022 | $765,000 | -3.2% | 321,292 | +86.8% | 0.00% | – |
Q4 2021 | $790,000 | -47.5% | 172,039 | -7.5% | 0.00% | – |
Q3 2021 | $1,505,000 | -17.4% | 185,910 | +0.4% | 0.00% | – |
Q2 2021 | $1,821,000 | -65.1% | 185,141 | -68.7% | 0.00% | – |
Q1 2021 | $5,218,000 | -5.0% | 591,727 | +10.2% | 0.00% | – |
Q4 2020 | $5,493,000 | +43.7% | 536,965 | +27.1% | 0.00% | – |
Q3 2020 | $3,822,000 | +34.8% | 422,640 | +6.4% | 0.00% | – |
Q2 2020 | $2,836,000 | +317.1% | 397,177 | +455.0% | 0.00% | – |
Q1 2020 | $680,000 | -23.6% | 71,557 | +5.8% | 0.00% | – |
Q4 2019 | $890,000 | – | 67,634 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nan Fung Group Holdings Ltd | 613,223 | $913,702 | 0.63% |
SECTORAL ASSET MANAGEMENT INC | 1,666,666 | $2,483,332 | 0.48% |
Sofinnova Investments, Inc. | 3,083,712 | $4,594,731 | 0.27% |
Novo Holdings A/S | 2,459,021 | $3,663,941 | 0.23% |
Tekla Capital Management LLC | 898,374 | $1,338,577 | 0.05% |
Blackstone Inc. | 1,678,984 | $2,501,686 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 187,000 | $278,630 | 0.01% |
Ensign Peak Advisors, Inc | 151,777 | $226,148 | 0.00% |
TCI Wealth Advisors, Inc. | 6,162 | $9,181 | 0.00% |
Tower Research Capital LLC (TRC) | 17,819 | $27 | 0.00% |